간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
감염병 진단/검사 시장 규모는 2027 년까지 2345 억 달러에 이를 것으로 예상되며, 2022-2027 년 예측 기간 동안 CAGR 5.8%로 성장할 것으로 예상됩니다. 감염병은 박테리아, 바이러스 등으로 인해 발생하며 국가의 의료 시스템에 큰 영향을 미칩니다.
Summary
Infectious Disease Testing/Diagnostic Market. The Infectious Disease Testing Market size is forecast to reach $23.45 billion by 2027, growing at a CAGR of 5.8% during the forecast period 2022-2027. Infectious disease is caused by bacteria, viruses, and others and has a huge impact on the Healthcare systems of the countries
Table of Contents
1. Infectious Disease Testing Market - Overview
1.1 Definitions and Scope
2. Infectious Disease Testing Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product & Solution
2.3 Key trends by End Users
2.4 Key trends by Geography
3. Infectious Disease Testing Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Infectious Disease Testing Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Infectious Disease Testing Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Infectious Disease Testing Market – By Product & Service(Market Size – $Million/$Billion)
6.1 Consumables
6.2 Instruments
6.3 Software & Service
7. Infectious Disease Testing Market – By Disease Type(Market Size – $Million/$Billion)
7.1 Hepatitis
7.2 Human Immunodeficiency Virus
7.3 Human Papillomavirus
7.4 Tuberculosis
7.5 Influenza
7.6 Others
8. Infectious Disease Testing Market – By Technology(Market Size – $Million/$Billion)
8.1 Immunodiagnostics
8.2 Clinical Microbiology
8.3 Polymerase Chain Reaction
8.4 DNA Microarray Technology
8.5 Next Generation Sequencing
8.6 Others
9. Infectious Disease Testing Market – By End Users(Market Size –$Million/$Billion)
9.1 Hospital/Clinical Laboratories
9.2 Reference Laboratories
9.3 Academics & Research Institutes
9.4 Others
10. Infectious Disease Testing Market - By Geography(Market Size –$Million/$Billion)
10.1 North America
10.1.1 U.S.
10.1.2 Mexico
10.1.3 Canada
10.2 Europe
10.2.1 U.K.
10.2.2 France
10.2.3 Germany
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 India
10.3.3 Japan
10.3.4 South Korea
10.3.5 Australia & New Zealand
10.3.6 Rest of APAC
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Africa
10.4.3 South America
11. Infectious Disease Testing Market - Entropy
12. Infectious Disease Testing Market Company Analysis
12.1 Company 1
12.2 Company 2
12.3 Company 3
12.4 Company 4
12.5 Company 5
12.6 Company 6
12.7 Company 7
12.8 Company 8
12.9 Company 9
12.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
감염병 진단/검사 시장 규모는 2027 년까지 2345 억 달러에 이를 것으로 예상되며, 2022-2027 년 예측 기간 동안 CAGR 5.8%로 성장할 것으로 예상됩니다. 감염병은 박테리아, 바이러스 등으로 인해 발생하며 국가의 의료 시스템에 큰 영향을 미칩니다.
Summary
Infectious Disease Testing/Diagnostic Market. The Infectious Disease Testing Market size is forecast to reach $23.45 billion by 2027, growing at a CAGR of 5.8% during the forecast period 2022-2027. Infectious disease is caused by bacteria, viruses, and others and has a huge impact on the Healthcare systems of the countries
Table of Contents
1. Infectious Disease Testing Market - Overview
1.1 Definitions and Scope
2. Infectious Disease Testing Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product & Solution
2.3 Key trends by End Users
2.4 Key trends by Geography
3. Infectious Disease Testing Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Infectious Disease Testing Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Infectious Disease Testing Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Infectious Disease Testing Market – By Product & Service(Market Size – $Million/$Billion)
6.1 Consumables
6.2 Instruments
6.3 Software & Service
7. Infectious Disease Testing Market – By Disease Type(Market Size – $Million/$Billion)
7.1 Hepatitis
7.2 Human Immunodeficiency Virus
7.3 Human Papillomavirus
7.4 Tuberculosis
7.5 Influenza
7.6 Others
8. Infectious Disease Testing Market – By Technology(Market Size – $Million/$Billion)
8.1 Immunodiagnostics
8.2 Clinical Microbiology
8.3 Polymerase Chain Reaction
8.4 DNA Microarray Technology
8.5 Next Generation Sequencing
8.6 Others
9. Infectious Disease Testing Market – By End Users(Market Size –$Million/$Billion)
9.1 Hospital/Clinical Laboratories
9.2 Reference Laboratories
9.3 Academics & Research Institutes
9.4 Others
10. Infectious Disease Testing Market - By Geography(Market Size –$Million/$Billion)
10.1 North America
10.1.1 U.S.
10.1.2 Mexico
10.1.3 Canada
10.2 Europe
10.2.1 U.K.
10.2.2 France
10.2.3 Germany
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 India
10.3.3 Japan
10.3.4 South Korea
10.3.5 Australia & New Zealand
10.3.6 Rest of APAC
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Africa
10.4.3 South America
11. Infectious Disease Testing Market - Entropy
12. Infectious Disease Testing Market Company Analysis
12.1 Company 1
12.2 Company 2
12.3 Company 3
12.4 Company 4
12.5 Company 5
12.6 Company 6
12.7 Company 7
12.8 Company 8
12.9 Company 9
12.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
